Camp4 Therapeutics CAMP
NASDAQ CAMP
$3.29 +0.13 (+4.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026)

Updated

Camp4 Therapeutics' (CAMP) Asset Utilization Ratio was 0.04 for Q2 2026, down 19.6% from 0.05 a year earlier but up 20.3% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Dating back to Q4 2024, Camp4 Therapeutics' Asset Utilization Ratio record includes 7 quarters.

  • By year, Asset Utilization Ratio came in at 0.01 in FY2024.
  • Five-year quarterly Asset Utilization Ratio spans a low of 0.01 in Q4 2024 and a high of 0.06 in Q3 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 0.04 (Q1 2026), 0.03 (Q4 2025) and 0.06 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Camp4 Therapeutics 191.17 Mn -179.26 Mn - 0.04
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.04
Dec 31, 2025 0.03
Sep 30, 2025 0.06
Jun 30, 2025 0.05
Mar 31, 2025 0.02
Dec 31, 2024 0.01
API Access

Camp4 Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CAMP&period=max&api_key=YOUR_API_KEY